RAD52 could predict overall survival for patients with renal clear cell carcinoma

Asian J Surg. 2023 Sep;46(9):3972-3974. doi: 10.1016/j.asjsur.2023.04.001. Epub 2023 Apr 20.

Authors

Mei Chen¹, Yuhan Xiao², Liying Zhang²

Affiliations

¹ Department of Urology, Yaan People's Hospital, Yaan, China. Electronic address: [email protected].
² Department of Urology, West China School of Medicine, West China Hospital, Sichuan University, China.

PMID: 37087350
DOI: 10.1016/j.asjsur.2023.04.001

No abstract available

Keywords: KIRC; Overall survival; RAD52; Tumor immune microenvironment.

Publication types

Letter

MeSH terms

Biomarkers, Tumor
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms*
Patients
Prognosis
Rad52 DNA Repair and Recombination Protein

Substances

Biomarkers, Tumor
RAD52 protein, human
Rad52 DNA Repair and Recombination Protein